Clinical Drug Development Process: Phases and Steps

Pharmacokinetics (PK) is the analysis and description of the disposition of a drug in the body, encompassing development of the mathematical description of all dispositional processes in the body, defined as ADME – absorption, distribution, metabolism, and elimination.

Pharmacokinetics definition  is the branch of pharmacology that relates systemic drug or toxicant exposure to their site of action, assisting in understanding efficacy and toxicity, and allowing predictions to be made of recurrence of drug or toxicant biotransformation. Pharmacokinetic studies are typically performed in healthy volunteers using single-dose administration of a novel compound, followed by blood and urine sampling at multiple time points for analysis, which allows for the calculation of half-life, bioavailability, concentration-time profiles and area under the curve (AUC) for both the unconjugated and conjugated forms of a compound. The information from these PK studies are used to assess safety and tolerability in future clinical trials and for eventual dose selection for phase I clinical trials.

When used with the technique of drug-receptor binding studies, pharmacokinetics helps to elucidate the relationship between the concentration of a medication at its site of action and its clinical effect. Therapeutic drug monitoring is the process by which a clinician obtains samples for quantification of drug concentrations in plasma, serum, or whole blood to assist pharmacotherapy management.

Pharmacokinetics is the characterization of drug movement in and through the body. It is a study of how the drugs are absorbed in the body, how it acts on the body, how long does it stay in the body and how it is eliminated from the body. It is a science which deals with transfer of drugs from its site of administration to their target site.

There are five critical steps in the U.S. drug development process, including many phases and stages within each of them. We will discuss these different phases and stages to develop an in-depth understanding of the entire process. Our clinical drug development process is relatively quick and straightforward. They are broken down into five steps to make them easier to remember. The first step is discovery and development, the second step is preclinical research, the third step is clinical development, the fourth step is FDA review and the fifth and final step is FDA post-market safety monitoring.

As part of the U.S. drug development process, there are five critical steps you will go through, each with their own phases & stages. Able to study and understand these different phases, you can ensure that you will be capable of working in this particular field. This course will provide you with a comprehensive understanding of the clinical drug development process, the different phases and stages within each step, how they relate to each other, as well as what factors are taken into account when making key decisions.

The clinical drug development process involves many phases and steps.

The post Clinical Drug Development Process: Phases and Steps appeared first on VOICENDO.

Brainwave Canal